Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Risk-Targeted Video Based Directly on Observed Therapy for Latent TB

NCT03783728 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.

NCT NCT03783728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03783728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Risk-Targeted Video Based Directly on Observed Therapy for Latent TB
Lead sponsor
St. Louis University
Phase
Observational
Overall status
Withdrawn
Start date
June 30, 2019
Completion date
January 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

latent tuberculosis